These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29845720)

  • 81. Synthesis and in vitro/in vivo antibacterial activity of oxazolidinones having thiocarbamate at C-5 on the A-ring and an amide- or urea-substituted [1,2,5]triazepane or [1,2,5]oxadiazepane as the C-ring.
    Suzuki H; Utsunomiya I; Shudo K; Fukuhara N; Iwaki T; Yasukata T
    Eur J Med Chem; 2013 Nov; 69():262-77. PubMed ID: 24044938
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Gold-Catalyzed Cyclization Leads to a Bridged Tetracyclic Indolenine that Represses β-Lactam Resistance.
    Xu W; Wang W; Wang X
    Angew Chem Int Ed Engl; 2015 Aug; 54(33):9546-9. PubMed ID: 26074499
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Design, synthesis, and structure-activity relationship studies of highly potent novel benzoxazinyl-oxazolidinone antibacterial agents.
    Xin Q; Fan H; Guo B; He H; Gao S; Wang H; Huang Y; Yang Y
    J Med Chem; 2011 Nov; 54(21):7493-502. PubMed ID: 21955296
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Design and evaluation of biological activities of 1,3-oxazolidinone derivatives bearing amide, sulfonamide, and thiourea moieties.
    Karaman N; Adil Zainel R; Kapkaç HA; Karaca Gençer H; Ilgın S; Karaduman AB; Karaküçük-İyidoğan A; Oruç-Emre EE; Koçyiğit-Kaymakçıoğlu B
    Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800057. PubMed ID: 30079557
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Synthesis and evaluation of novel sulfenamides as novel anti Methicillin-resistant Staphylococcus aureus agents.
    Shang JL; Guo H; Li ZS; Ren B; Li ZM; Dai HQ; Zhang LX; Wang JG
    Bioorg Med Chem Lett; 2013 Feb; 23(3):724-7. PubMed ID: 23265879
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Novel 4-N-substituted aryl but-3-ene-1,2-dione derivatives of piperazinyloxazolidinones as antibacterial agents.
    Varshney V; Mishra NN; Shukla PK; Sahu DP
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6810-2. PubMed ID: 19837588
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Synthesis of (+)-Darwinolide, a Biofilm-Penetrating Anti-MRSA Agent.
    Siemon T; Steinhauer S; Christmann M
    Angew Chem Int Ed Engl; 2019 Jan; 58(4):1120-1122. PubMed ID: 30451352
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Synthesis and in vitro antibacterial activity of novel 3-azabicyclo[3.3.0]octanyl oxazolidinones.
    Bhattarai D; Lee SH; Seo SH; Nam G; Kang SB; Pae AN; Kim EE; Oh T; Cho SN; Keum G
    Chem Biol Drug Des; 2012 Sep; 80(3):388-97. PubMed ID: 22553981
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Synthesis and antibacterial evaluation of isoxazolinyl oxazolidinones: Search for potent antibacterial.
    Varshney V; Mishra NN; Shukla PK; Sahu DP
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3573-6. PubMed ID: 19447611
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The synthesis and antimicrobial evaluation of a new series of isoxazolinyl oxazolidinones.
    Weidner-Wells MA; Werblood HM; Goldschmidt R; Bush K; Foleno BD; Hilliard JJ; Melton J; Wira E; Macielag MJ
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3069-72. PubMed ID: 15149646
    [TBL] [Abstract][Full Text] [Related]  

  • 91. An Update on the Structure of Oxazolidinone Analogs and a Comparison with Linezolid in Terms of In Vitro and Intracellular Efficacy against Clinically Relevant Bacterial Species.
    Tang Q; Zhao Y; Xu B; Gong P; Wang D
    Jpn J Infect Dis; 2017 Nov; 70(6):678-681. PubMed ID: 28890512
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cheminformatic Profiling and Hit Prioritization of Natural Products with Activities against Methicillin-Resistant
    Oselusi SO; Egieyeh SA; Christoffels A
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34208597
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Structure-antibacterial activity of arylcarbonyl- and arylsulfonyl-piperazine 5-triazolylmethyl oxazolidinones.
    Phillips OA; Udo EE; Ali AA; Samuel SM
    Eur J Med Chem; 2007 Feb; 42(2):214-25. PubMed ID: 17140706
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of varied substituents on the antibacterial activity of triazolylmethyl oxazolidinones.
    Phillips OA; Udo EE; Abdel-Hamid ME; Varghese R
    Arch Pharm (Weinheim); 2012 Oct; 345(10):790-803. PubMed ID: 22886578
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Synthesis and antibacterial activities of chiral 1,3-oxazinan-2-one derivatives.
    Wang G; Ella-Menye JR; Sharma V
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2177-81. PubMed ID: 16495055
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Synthesis and antibacterial activities of marine natural product ianthelliformisamines and subereamine synthetic analogues.
    Khadake SN; Karamathulla S; Jena TK; Monisha M; Tuti NK; Khan FA; Anindya R
    Bioorg Med Chem Lett; 2021 May; 39():127883. PubMed ID: 33662536
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Divergent Synthesis of Novel Cylindrocyclophanes that Inhibit Methicillin-Resistant Staphylococcus aureus (MRSA).
    Freudenreich JJ; Bartlett S; Robertson NS; Kidd SL; Forrest S; Sore HF; Galloway WRJD; Welch M; Spring DR
    ChemMedChem; 2020 Jul; 15(14):1289-1293. PubMed ID: 32424962
    [TBL] [Abstract][Full Text] [Related]  

  • 98. An azido-oxazolidinone antibiotic for live bacterial cell imaging and generation of antibiotic variants.
    Phetsang W; Blaskovich MA; Butler MS; Huang JX; Zuegg J; Mamidyala SK; Ramu S; Kavanagh AM; Cooper MA
    Bioorg Med Chem; 2014 Aug; 22(16):4490-8. PubMed ID: 25023540
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Biologically Inspired Total Synthesis of Ulbactin F, an Iron-Binding Natural Product.
    Shapiro JA; Morrison KR; Chodisetty SS; Musaev DG; Wuest WM
    Org Lett; 2018 Sep; 20(18):5922-5926. PubMed ID: 30199265
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Studies on Comprehensive Total Synthesis of Natural and Pseudo-Natural Products for Drug Discovery.
    Nakayama A
    Chem Pharm Bull (Tokyo); 2024; 72(5):422-431. PubMed ID: 38692857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.